|Event Name||Webinar: Pathway Studio and Reaxys Medicinal Chemistry - Using Elsevier’s R&D portfolio to explore drug targets for Schizophrenia featuring Pathway Studio and Reaxys Medicinal Chemistry|
|Start Date||29th Jul 2015|
Please join us as drug discovery expert, Jim Rinker, will discuss the process for exploring drug targets for schizophrenia using a specific workflow between Reaxys Medicinal Chemistry and Pathway Studio. Beginning with mapping known schizophrenia drugs to regulators, Mr. Rinker will walk through the keys steps in finding the proper drug used to improve cognitive function. This step-by-step method of research and data extraction will demonstrate how using these platforms can help identify side effects, build a consensus model, properly profile drugs and effectively map cognition.
Please note this webinar is being given at a time that is convenient for Asia-Pacific, however all our customers are welcome to attend.
Wed, Jul 29, 2015 12:00 AM - 1:00 AM EDT